Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov;21(11):1141-8.
doi: 10.1002/pon.3196. Epub 2012 Oct 1.

Brain vulnerability to chemotherapy toxicities

Tim A Ahles  1
Affiliations
Review

Brain vulnerability to chemotherapy toxicities

Tim A Ahles. Psychooncology. 2012 Nov.

Abstract

Chemotherapy-induced cognitive changes have been an increasing concern among cancer survivors. By using adjuvant treatment for breast cancer as the prototype, this manuscript reviews research from neuropsychological, imaging, genetic, and animal model studies that have examined the clinical presentation and potential mechanisms for cognitive changes associated with exposure to chemotherapy. An impressive body of research supports the hypothesis that a subgroup of patients is vulnerable to post-treatment cognitive changes, although not exclusively related to chemotherapy. Further, imaging and animal model studies provide accumulating evidence of putative mechanisms for chemotherapy-induced cognitive change. Models of aging are also reviewed in support of the proposal that cognitive changes associated with cancer and cancer treatments can be viewed in the context of factors that affect the trajectory of normal aging.

Keywords: brain vulnerability; cancer; chemotherapy; cognition; oncology.

PubMed Disclaimer

Conflict of interest statement

I have no conflict of interest to report with regard to the preparation of this manuscript.

Figures

Figure 1
Figure 1
Impact of Change in Brain Resources on Cognitive Performance by Age The same change in brain resources can have a minimal effect on cognitive performance in a young adult (a), a moderate effect in an older adult with high cognitive reserve (b) and a greater effect on an older adult with low cognitive reserve (c).
Figure 2
Figure 2
Trajectories of Cognitive Change
See this image and copyright information in PMC

References

    1. Oxman TE, Silberfarb PM. Serial cognitive testing in cancer patients receiving chemotherapy. American Journal of Psychiatry. 1980;137:1263–1265. - PubMed
    1. Tannock IF, Ahles TA, Ganz PA, van Dam FS. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology. 2004;22:2233–2239. - PubMed
    1. Vardy J, Wefel JS, Ahles TA, et al. Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice Cognitive Workshop. Annals of Oncology. 2008;19:623–629. - PubMed
    1. Wefel JS, Vardy J, Ahles TA, Schagen S. Internation Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in cancer patients. Lancet Oncology. 2011;12:703–708. - PubMed
    1. Wefel JS, Lenzi R, Theriault RL. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal study. Cancer. 2004;100:2292–2299. - PubMed

Publication types

MeSH terms

Substances